Nuveen Multistate Trust III has provided a financial update through its latest NPORT-P filing, revealing its financial position as of August 31, 2026. This filing is significant as it showcases the trust's total assets of approximately $135.5 million, with net assets reported at around $135 million.
The filing indicates that the trust holds total liabilities of about $557,000, which underscores its solid asset base relative to its liabilities. The report also highlights the trust's continued focus on municipal bond investments, particularly in Georgia, where it has a diverse portfolio of bonds.
Background
Nuveen Multistate Trust III is an investment trust primarily focused on municipal securities. The trust is incorporated in Massachusetts and has been active in the investment sector, particularly in the management of municipal bonds. The trust's recent filings include multiple NPORT-P forms, with the latest dated October 29, 2026, under accession number 0001020661-26-000062.
What the Filing Says
The recent filing details the trust's financial metrics, including:
- Total assets: $135,520,480
- Total liabilities: $556,976
- Net assets: $134,963,504
- Reporting period end date: August 31, 2026
Additionally, the filing indicates that the trust's assets are primarily invested in municipal bonds, reflecting its strategic investment focus.
Impact
This update is likely to affect the trust's investors and stakeholders, as it provides insight into the trust's financial health and investment strategy. As competition in the municipal bond market intensifies, the performance metrics outlined in this filing will be crucial for current and potential investors.
What's Next
The filing does not say what happens next, but the trust's ongoing performance will be monitored closely as it continues to navigate the municipal bond market.
Read Next
Kinney Virginia reports stock transaction in NRG Energy
Fitzgerald Scott Michael reports share transaction at StubHub
Baker Eric Howard Acquires 18,130 Shares of StubHub Holdings
Hart Scott Barton Acquires Shares in NRG Energy, Inc.
Arcutis Biotherapeutics reports stock ownership update
Jazz Pharmaceuticals Director Sells 6,000 Shares in Transaction





